Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Blanca Medrano-Engay"'
Autor:
Marcio M. Andrade-Campos, Laura López de Frutos, Jorge J. Cebolla, Irene Serrano-Gonzalo, Blanca Medrano-Engay, Mercedes Roca-Espiau, Beatriz Gomez-Barrera, Jorge Pérez-Heredia, David Iniguez, Pilar Giraldo
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-11 (2020)
Abstract Background Since enzyme replacement therapy for Gaucher disease (MIM#230800) has become available, both awareness of and the natural history of the disease have changed. However, there remain unmet needs such as the identification of patient
Externí odkaz:
https://doaj.org/article/29234a24352744b8afb0e10a2ead564d
Autor:
Mercedes Roca-Espiau, Marcio Andrade-Campos, Jorge J. Cebolla, Laura López de Frutos, Blanca Medrano-Engay, Maria-Pilar López-Royo, Pilar Giraldo
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 14, Iss 1, Pp 1-8 (2019)
Abstract Background Chronic fatigue (CFg) is a prevalent symptom in Gaucher disease (GD) at diagnosis (79%) and remains in a quarter of patients after years of therapy. Bone abnormalities are present in over 70% and peripheral neuropathy in about 11%
Externí odkaz:
https://doaj.org/article/5cb24522df0d45d8910ae3351f357b65
Autor:
Irene Serrano-Gonzalo, Marcio Andrade-Campos, David Iñiguez, Beatriz Gomez-Barrera, Jorge Perez-Heredia, Blanca Medrano-Engay, Mercedes Roca-Espiau, Laura López de Frutos, Pilar Giraldo, Jorge J. Cebolla
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-11 (2020)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Orphanet Journal of Rare Diseases
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Orphanet Journal of Rare Diseases
Background Since enzyme replacement therapy for Gaucher disease (MIM#230800) has become available, both awareness of and the natural history of the disease have changed. However, there remain unmet needs such as the identification of patients at risk
Autor:
A. Almeida-Calpe, Pilar Giraldo, Blanca Medrano-Engay, C.B. García-García, L. López de Frutos, M.P. Ribate
Publikováno v:
Chemico-biological interactions. 345
Several therapeutic options are available for type 1 Gaucher disease (GD1), including enzymatic replacement therapy (ERT) and substrate reduction therapy (SRT). Eliglustat is a selective inhibitor of glucosylceramide synthase that is extensively meta
Autor:
Jorge J. Cebolla Sanz, Beatriz Gomez-Barrera, Maria Blanca Medrano Engay, Laura López de Frutos, Mercedes Roca Espiau, David Iñiguez, Marcio Andrade-Campos, Jorge Perez-Heredia
Publikováno v:
Molecular Genetics and Metabolism. 129:S21-S22
Autor:
Pilar Giraldo, Mercedes Roca-Espiau, Jorge J. Cebolla, Marcio Andrade-Campos, Laura López de Frutos, Blanca Medrano-Engay, Maria-Pilar López-Royo
Publikováno v:
R-USJ: Repositorio Institucional de la Universidad San Jorge
Universidad San Jorge (USJ)
Journal of Orthopaedic Surgery and Research
Journal of Orthopaedic Surgery and Research, Vol 14, Iss 1, Pp 1-8 (2019)
Universidad San Jorge (USJ)
Journal of Orthopaedic Surgery and Research
Journal of Orthopaedic Surgery and Research, Vol 14, Iss 1, Pp 1-8 (2019)
Background Chronic fatigue (CFg) is a prevalent symptom in Gaucher disease (GD) at diagnosis (79%) and remains in a quarter of patients after years of therapy. Bone abnormalities are present in over 70% and peripheral neuropathy in about 11% of the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3619c2bda57bd4f0ffe43fe6f824f7
https://doi.org/10.1186/s13018-019-1452-y
https://doi.org/10.1186/s13018-019-1452-y
Autor:
Javier de la Serna, Jose Manuel Puerta, Rafael Franco, Antonio Acedo, Blanca Medrano-Engay, Marcio Andrade-Campos, Cristina Gil-Cortes, Vicente Giner, Olga Salamero, Lucia Villalon, Abelardo Bárez, Paz Latre, Koldo Atutxa, Ines Loyola, Inmaculada Roig, Vicente Diaz-Morant, Ma Angeles Fernández-Galán, Elisa Luño, Roberto Hernández-Martin, Angela Ibañez, Pilar Giraldo, Pilar Irún, Miguel Pocovi, Pilar Alfonso, Margarita Blanes
Publikováno v:
BLOOD CELLS MOLECULES AND DISEASES
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
RUNA. Repositorio da Consellería de Sanidade e Sergas
Servizo Galego de Saúde (SERGAS)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
RUNA. Repositorio da Consellería de Sanidade e Sergas
Servizo Galego de Saúde (SERGAS)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
We report data from a prospective, observational study (ZAGAL) evaluating miglustat 100mg three times daily orally. in treatment-naïve patients and patients with type 1 Gaucher Disease (GD1) switched from previous enzyme replacement therapy (ERT). C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84d50d2f513f80f4a6efccd4dcaa63c8
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2366
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2366
Publikováno v:
Journal of Pharmacy and Pharmacology. 5
Autor:
Roberto Hernández-Martin, Soledad Noya, Javier de la Serna, Pilar Giraldo, Ana Roy, Javier García-Frade, Elisa Luño, Vicente Diaz-Morant, Koldo Atutxa, Lucia Villalon, Blanca Medrano Engay
Publikováno v:
Molecular Genetics and Metabolism. 123:S93-S94
Autor:
Blanca Medrano-Engay, Pilar Giraldo, Mercedes Roca-Espiau, Jorge J. Cebolla, Beatriz Gomez-Barrera, Laura López de Frutos, David Iñiguez, Marcio Andrade-Campos
Publikováno v:
Blood. 134:2323-2323
Introduction Type 1 Gaucher disease (GD)(OMIM # 230800), has a pan-ethnic distribution, in Spain its prevalence is about 1/100,000. Since more than twenty years the impact of therapies in the awareness of the disease is changing the characteristics a